$VTEX

Gomide de Faria Mariano sold $20K of VTEX (indirect holdings)

Gomide de Faria Mariano (Chief Executive Officer) sold 4,808 indirectly-held shares of VTEX (VTEX) at $4.09 on 2026-07-13 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gomide de Faria Mariano
Published Jul 15, 2026, 8:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 15, 2026, 8:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VTEX
Neutral
medium confidence
Mentioned
$VTEX
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VTEXNeutralLow
01

Why it matters

The disclosure updates the record of insider activity and can influence short-term sentiment, but it does not provide new guidance, contracts, litigation, or financial results.

02

Market read

Traders may monitor insider selling for sentiment, but this specific filing is unlikely to drive a durable repricing without accompanying fundamentals.

03

What to watch

Indirect holdings and the post-transaction share count may matter for interpreting whether the sale is routine versus unusual, but the article provides only this single transaction.

Relevance 2/10Novelty 3/10Timing: new Form 4 filed 2026-07-15, covering a sale executed 2026-07-13

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for VTEX.

Company-level read

Ticker impact

$VTEXNeutralMedium confidence
Context

VTEX CEO Gomide de Faria Mariano filed a Form 4 open-market sale of 4,808 shares at $4.0900 on 2026-07-13 under a 10b5-1 plan.

Expected impact

Likely limited, with any impact more sentiment-driven than fundamental.

Evidence & confidence

The filing is a routine 10b5-1 planned sale by the CEO; it provides timing and size but no new operational or financial information.

Market effects

No clear sector read-through; insider sale does not indicate industry-wide change.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations.

Key entities

  • VTEX

    Company whose CEO filed the Form 4 insider transaction.

  • Gomide de Faria Mariano

    VTEX CEO who sold shares via an open-market transaction under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VTEXMed

VTEX (VTEX) Just Turned A Profit Corner, But Growth Is Slowing

VTEX (NYSE:VTEX) reported Q2 2026 results showing improved profitability with non-GAAP income from operations up 62.4% YoY to $13.8M, and free cash flow up 79.1% to $12.7M. However, revenue growth slowed to 1.3% YoY on an FX-neutral basis, with management expecting flat growth for Q3. The company repurchased 6.2M shares for $23.2M during the quarter.

$VTEXMedAI 8/10

VTEX (VTEX) Q2 2026 Earnings Call Transcript

VTEX reported Q2 2026 results in an earnings call. GMV was $5.7B, up 7% FX-neutral. Subscription revenue was $63.8M, up 1.3% FX-neutral. Non-GAAP operating income rose 62% to $13.8M, with a 21.4% margin. Free cash flow was $12.7M, up 79%. Q3 guidance calls for flat FX-neutral subscription growth.

$VTEXMedAI 8/10

VTEX Q2 Earnings Call Highlights

VTEX (NYSE:VTEX) reported Q2 margin and cash flow improvement and guided for Q3 and full-year low-single-digit FX-neutral subscription revenue growth and low-20% non-GAAP operating and free cash flow margins. Q2 non-GAAP subscription gross margin rose to 81.8%. Free cash flow rose 79% to $12.7M. VTEX repurchased 6.2M shares at $3.76.

$VTEXMed

VTEX (VTEX): Financial results for Q2 2026

VTEX (VTEX) furnished an SEC Form 6-K — earnings release. VTEX Reports Second Quarter 2026 Financial Results Subscription revenue grew 11.4% (+1.3% FXN), with GMV up 17.8% (+7.0% FXN) Non-GAAP income from operations increased 62.4% to US$13.8 million, reaching a 21.4% margin Free cash flow increased 79.1% to US$12.7 million, reaching a